4.6 Article

The Phosphoinositide-Binding Protein ZF21 Regulates ECM Degradation by Invadopodia

Journal

PLOS ONE
Volume 8, Issue 1, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0050825

Keywords

-

Funding

  1. CREST project from JST
  2. MEXT [22220014, 23790109]
  3. Grants-in-Aid for Scientific Research [22220014, 23790109] Funding Source: KAKEN

Ask authors/readers for more resources

During the process of tumor invasion, cells require footholds on extracellular matrices (ECM) that are created by forming focal adhesions (FAs) using integrins. On the other hand, cells must degrade the ECM barrier using extracellular proteases including MMPs in the direction of cell movement. Degradation occurs at the leading edges or invadopodia of cells, which are enriched in proteases and adhesion molecules. Recently, we showed that the phosphoinositide-binding protein ZF21 regulates FA disassembly. ZF21 increased cell migration by promoting the turnover of FAs. In addition, ZF21 promotes experimental tumor metastasis to lung in mice and its depletion suppresses it. However, it is not known whether ZF21 regulates cancer cell invasion in addition to its activity on FAs. In this study, we demonstrate that ZF21 also regulates invasion of tumor cells, whereas it does not affect the overall production of MMP-2, MMP-9, and MT1-MMP by the cells. Also, we observe that the ECM-degrading activity specifically at the invadopodia is severely abrogated. In the ZF21 depleted cells MT1-MMP cannot accumulate to the invadopodia and thereby cannot contribute to the ECM degradation. Thus, this study demonstrates that ZF21 is a key player regulating multiple aspects of cancer cell migration and invasion. Possible mechanisms regulating ECM degradation at the invadopodia are discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Srv2/CAP is required for polarized actin cable assembly and patch internalization during clathrin-mediated endocytosis

Junko Y. Toshima, Chika Horikomi, Asuka Okada, Makiko N. Hatori, Makoto Nagano, Atsushi Masuda, Wataru Yamamoto, Daria Elisabeth Siekhaus, Jiro Toshima

JOURNAL OF CELL SCIENCE (2016)

Article Biochemistry & Molecular Biology

Matrix metalloproteinase-14 mediates formation of bile ducts and hepatic maturation of fetal hepatic progenitor cells

Satoshi Otani, Sei Kakinuma, Akihide Kamiya, Fumio Goto, Shun Kaneko, Masato Miyoshi, Tomoyuki Tsunoda, Yu Asano, Fukiko Kawai-Kitahata, Sayuri Nitta, Toru Nakata, Ryuichi Okamoto, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Yasuhiro Asahina, Tomoyuki Yamaguchi, Naohiko Koshikawa, Motoharu Seiki, Hiromitsu Nakauchi, Mamoru Watanabe

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Article Pathology

Immunohistochemical demonstration of EphA2 processing by MT1-MMP in invasive cutaneous squamous cell carcinoma

Ryoko Tatsukawa, Kaori Koga, Mikiko Aoki, Naohiko Koshikawa, Shinichi Imafuku, Juichiro Nakayama, Kazuki Nabeshima

VIRCHOWS ARCHIV (2016)

Article Cell Biology

Distinct roles for plasma membrane Ptdlns(4)P and Ptdlns(4,5)P2 during receptor-mediated endocytosis in yeast

Wataru Yamamoto, Suguru Wada, Makoto Nagano, Kaito Aoshima, Darla Elisabeth Siekhaus, Junko Y. Toshima, Jiro Toshima

JOURNAL OF CELL SCIENCE (2018)

Article Cell Biology

Specific detection of soluble EphA2 fragments in blood as a new biomarker for pancreatic cancer

Naohiko Koshikawa, Tomoko Minegishi, Hirofumi Kiyokawa, Motoharu Seiki

CELL DEATH & DISEASE (2017)

Article Biochemistry & Molecular Biology

Live-cell imaging of early coat protein dynamics during clathrin-mediated endocytosis

Masashi Miyashita, Ryutaro Kashikuma, Makoto Nagano, Junko Y. Toshima, Jiro Toshima

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2018)

Article Multidisciplinary Sciences

Rab5-independent activation and function of yeast Rab7-like protein, Ypt7p, in the AP-3 pathway

Hiroki Shimamura, Makoto Nagano, Keita Nakajima, Junko Y. Toshima, Jiro Toshima

PLOS ONE (2019)

Article Biochemical Research Methods

Utility of a Reverse Phase Protein Array to Evaluate Multiple Biomarkers in Diffuse Large B-Cell Lymphoma

Masaki Suzuki, Atsushi Muroi, Masanori Nojima, Ayumi Numata, Hirotaka Takasaki, Rika Sakai, Tomoyuki Yokose, Yohei Miyagi, Naohiko Koshikawa

PROTEOMICS CLINICAL APPLICATIONS (2020)

Article Oncology

NH2-terminal fragment of ZF21 protein suppresses tumor invasion via inhibiting the interaction of ZF21 with FAK

Makoto Nagano, Daisuke Hoshino, Jiro Toshima, Motoharu Seiki, Naohiko Koshikawa

CANCER SCIENCE (2020)

Article Oncology

Novel LAMC2 fusion protein has tumor-promoting properties in ovarian carcinoma

Hoshino Daisuke, Hisamori Kato, Kazuhiro Fukumura, Akila Mayeda, Yohei Miyagi, Motoharu Seiki, Naohiko Koshikawa

Summary: Laminins, composed of alpha, beta, and gamma chains, play a critical role in cancer progression. A novel short form of Lm-gamma 2 (Lm-gamma 2F) can activate the EGFR/AKT pathways more effectively, promoting proliferation and motility of ovarian cancer cells. The translocation between LAMC2 and NR6A1 genes is crucial for the malignant growth and progression of ovarian cancer cells.

CANCER SCIENCE (2021)

Review Oncology

Proteolytic cleavage of membrane proteins by membrane type-1 MMP regulates cancer malignant progression

Kazuki Ikeda, Ryo Kaneko, Eiki Tsukamoto, Nobuaki Funahashi, Naohiko Koshikawa

Summary: This paper discusses the failure of developing cancer therapies using inhibitors that target matrix metalloproteinases (MMPs), particularly membrane type-1 MMP (MT1-MMP), due to the specificity of MMP inhibitors and the multiple functions of MMPs. It suggests that new drug development should focus on the ability of MT1-MMP to break down substrates and regulate the functions of proteins that promote tumor malignancy. The paper also discusses two protein fragments generated by limited cleavage that could serve as a basis for developing new cancer therapies and diagnostic techniques.

CANCER SCIENCE (2023)

Review Oncology

Study on the tumor-induced angiogenesis using mathematical models

Takashi Suzuki, Dhisa Minerva, Koichi Nishiyama, Naohiko Koshikawa, Mark Andrew Joseph Chaplain

CANCER SCIENCE (2018)

Article Oncology

Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer

Masatoshi Nakagawa, Takashi Karashima, Masayuki Kamada, Eisaku Yoshida, Toru Yoshimura, Masanori Nojima, Keiji Inoue, Taro Shuin, Motoharu Seiki, Naohiko Koshikawa

BIOMARKER RESEARCH (2017)

Article Oncology

Serum monomeric laminin-2 as a novel biomarker for hepatocellular carcinoma

Hirofumi Kiyokawa, Hiroshi Yasuda, Ritsuko Oikawa, Chiaki Okuse, Nobuyuki Matsumoto, Hiroki Ikeda, Tsunamasa Watanabe, Hiroyuki Yamamoto, Fumio Itoh, Takehito Otsubo, Toru Yoshimura, Eisaku Yoshida, Masatoshi Nakagawa, Naohiko Koshikawa, Motoharu Seiki

CANCER SCIENCE (2017)

Correction Oncology

Development of a New Tracking Tool for the Human Monomeric Laminin-γ2 Chain In Vitro and In Vivo (vol 68, pg 530, 2008)

N. Koshikawa, T. Minegishi, A. K. Nabeshim, M. Seiki

CANCER RESEARCH (2016)

No Data Available